Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1934 1
1940 2
1941 1
1945 2
1946 1
1947 1
1948 1
1949 4
1950 1
1951 5
1952 7
1953 9
1954 12
1955 6
1956 13
1957 9
1958 16
1959 22
1960 13
1961 13
1962 18
1963 37
1964 76
1965 40
1966 46
1967 44
1968 60
1969 62
1970 79
1971 80
1972 113
1973 85
1974 81
1975 166
1976 193
1977 153
1978 199
1979 203
1980 252
1981 349
1982 369
1983 475
1984 554
1985 633
1986 631
1987 759
1988 840
1989 1009
1990 989
1991 1079
1992 1162
1993 1232
1994 1405
1995 1362
1996 1583
1997 1700
1998 1775
1999 1795
2000 1968
2001 1942
2002 2121
2003 2303
2004 2578
2005 2715
2006 2810
2007 3111
2008 3463
2009 3767
2010 3924
2011 4077
2012 4313
2013 4687
2014 4862
2015 4956
2016 5043
2017 5225
2018 5108
2019 5019
2020 5200
2021 4786
2022 4185
2023 3749
2024 4414
2025 5073
2026 4013
2027 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114,912 results

Results by year

Filters applied: . Clear all
Page 1
Making, Cloning, and the Expression of Human Insulin Genes in Bacteria: The Path to Humulin.
Riggs AD. Riggs AD. Endocr Rev. 2021 May 25;42(3):374-380. doi: 10.1210/endrev/bnaa029. Endocr Rev. 2021. PMID: 33340315 Free PMC article.
This question was answered in 1978 and in 1979 with the successful expression in E. coli of 2 mammalian hormones, first somatostatin and then human insulin. The successful production of human insulin in bacteria provided, for the first time, a practica …
This question was answered in 1978 and in 1979 with the successful expression in E. coli of 2 mammalian hormones, first somatostatin and the …
Anti-Islet Autoantibodies in Type 1 Diabetes.
Kawasaki E. Kawasaki E. Int J Mol Sci. 2023 Jun 11;24(12):10012. doi: 10.3390/ijms241210012. Int J Mol Sci. 2023. PMID: 37373160 Free PMC article. Review.
Anti-islet autoantibodies serve as key markers in immune-mediated type 1 diabetes (T1D) and slowly progressive T1D (SPIDDM), also known as latent autoimmune diabetes in adults (LADA). Autoantibodies to insulin (IAA), glutamic acid decarboxylase (GADA), tyrosine phosphatase …
Anti-islet autoantibodies serve as key markers in immune-mediated type 1 diabetes (T1D) and slowly progressive T1D (SPIDDM), also known as l …
Effectiveness and safety of early insulin glargine administration in combination with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: A randomized controlled trial.
Thammakosol K, Sriphrapradang C. Thammakosol K, et al. Diabetes Obes Metab. 2023 Mar;25(3):815-822. doi: 10.1111/dom.14929. Epub 2022 Dec 20. Diabetes Obes Metab. 2023. PMID: 36479786 Clinical Trial.
AIM: To determine the effectiveness and safety of early combination of insulin glargine with intravenous (IV) insulin infusion compared with IV insulin infusion alone in the management of diabetic ketoacidosis (DKA). ...The 'early glargine' group was given su …
AIM: To determine the effectiveness and safety of early combination of insulin glargine with intravenous (IV) insulin infusion …
Effect of Yoga and Walking on Glycemic Control for the Management of Type 2 Diabetes: A Systematic Review and Meta-analysis.
Dhali B, Chatterjee S, Sundar Das S, Cruz MD. Dhali B, et al. J ASEAN Fed Endocr Soc. 2023;38(2):113-122. doi: 10.15605/jafes.038.02.20. Epub 2023 Sep 19. J ASEAN Fed Endocr Soc. 2023. PMID: 38045671 Free PMC article.
RESULTS: Sixteen studies were included in this systematic review, where 1820 participants were allocated to one of the following interventions: yoga, walking, and without any regular exercise (control group). Participants were between 17-75 years of age. Compared to the co …
RESULTS: Sixteen studies were included in this systematic review, where 1820 participants were allocated to one of the following interventio …
Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function.
Herold KC, Gitelman SE, Gottlieb PA, Knecht LA, Raymond R, Ramos EL. Herold KC, et al. Diabetes Care. 2023 Oct 1;46(10):1848-1856. doi: 10.2337/dc23-0675. Diabetes Care. 2023. PMID: 37607392 Free PMC article.
RESEARCH DESIGN AND METHODS: To provide confirmatory evidence of the effects of teplizumab on preserving endogenous insulin production, an integrated analysis of C-peptide data from 609 patients (n = 375 patients receiving teplizumab and n = 234 control patients) from five …
RESEARCH DESIGN AND METHODS: To provide confirmatory evidence of the effects of teplizumab on preserving endogenous insulin productio …
Doping and sports endocrinology: growth hormone, IGF-1, insulin, and erythropoietin.
García-Arnés JA, García-Casares N. García-Arnés JA, et al. Rev Clin Esp (Barc). 2023 Mar;223(3):181-187. doi: 10.1016/j.rceng.2023.01.005. Epub 2023 Feb 1. Rev Clin Esp (Barc). 2023. PMID: 36736729 Review.
This work reviews growth hormone and its releasing peptides, insulin-like growth factor 1 as the main growth factor, insulin, and erythropoietin and other agents that affect erythropoiesis. ...
This work reviews growth hormone and its releasing peptides, insulin-like growth factor 1 as the main growth factor, insulin, …
The Case for Using Human Insulin.
Davidson MB. Davidson MB. Am J Med. 2020 Feb;133(2):e23-e24. doi: 10.1016/j.amjmed.2019.06.033. Epub 2019 Jul 11. Am J Med. 2020. PMID: 31301295 No abstract available.
Continuous Glucose Monitoring-Guided Insulin Administration in Hospitalized Patients With Diabetes: A Randomized Clinical Trial.
Spanakis EK, Urrutia A, Galindo RJ, Vellanki P, Migdal AL, Davis G, Fayfman M, Idrees T, Pasquel FJ, Coronado WZ, Albury B, Moreno E, Singh LG, Marcano I, Lizama S, Gothong C, Munir K, Chesney C, Maguire R, Scott WH, Perez-Guzman MC, Cardona S, Peng L, Umpierrez GE. Spanakis EK, et al. Diabetes Care. 2022 Oct 1;45(10):2369-2375. doi: 10.2337/dc22-0716. Diabetes Care. 2022. PMID: 35984478 Free PMC article. Clinical Trial.
Patients in the standard of care (POC group) wore a blinded Dexcom G6 CGM with insulin dose adjusted based on POC results, while in the CGM group, insulin adjustment was based on daily CGM profile. ...CONCLUSIONS: The inpatient use of real-time Dexcom G6 CGM is safe …
Patients in the standard of care (POC group) wore a blinded Dexcom G6 CGM with insulin dose adjusted based on POC results, while in t …
Type 1 diabetes: A new vision of the disease based on endotypes.
Weston CS, Boehm BO, Pozzilli P. Weston CS, et al. Diabetes Metab Res Rev. 2024 Feb;40(2):e3770. doi: 10.1002/dmrr.3770. Diabetes Metab Res Rev. 2024. PMID: 38450851 Review.
Furthermore, the treatment of T1D is essentially universal and indiscriminate-with patients administering insulin at varying dosages and frequencies to maintain adequate glycaemic control. However, it is now well understood that T1D is a heterogeneous disease with many dif …
Furthermore, the treatment of T1D is essentially universal and indiscriminate-with patients administering insulin at varying dosages …
Efficacy of Semaglutide in Overweight and Obese Patients with Type 1 Diabetes.
Garg SK, Kaur G, Haider Z, Rodriquez E, Beatson C, Snell-Bergeon J. Garg SK, et al. Diabetes Technol Ther. 2024 Mar;26(3):184-189. doi: 10.1089/dia.2023.0490. Diabetes Technol Ther. 2024. PMID: 38444317
The continuous glucose monitors (CGM), insulin pump use, baseline BMI and body weight were also similar in the two groups. Baseline glycosylated hemoglobin (HbA1c) was insignificantly lower in the semaglutide group (7.6% vs. 8.2%, respectively; P = non-significant [NS]). T …
The continuous glucose monitors (CGM), insulin pump use, baseline BMI and body weight were also similar in the two groups. Baseline g …
114,912 results
You have reached the last available page of results. Please see the User Guide for more information.